Search Results

585/09 : Type 2 Diabetes. SMC Restriction: Liraglutide is restricted to use as a third-line antidiabetic agent.

1044/15 : For the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with basal insulin when this, together with diet and exercise, does not provide adequate...

1088/15 : Treatment of adults with type 2 diabetes mellitus to improve glycaemic control in combination with oral glucose-lowering medicinal products when these alone or combined with a GLP-1 receptor...

1192/16 : As monotherapy for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control when diet and exercise alone do not provide adequate glycaemic control in patients for w...

SMC2455 : As an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index (BMI) of: ≥30kg/m^2 (obese), or ≥27kg/m^2 to <...